Latest Breaking News On - Medincrease provider network - Page 1 : comparemela.com

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it.

United statesDan forchePreludedx dcisionAndrew wadeCory dunnNational cancer institutePrelude corporation preludedxPrelude corporationMedincrease healthMedincrease provider networkUniversity of california san franciscoMedincrease enables availabilityMedincrease health plansLinda plasterChief executive officerCalifornia san francisco